Power Law company profile

Alexion Pharmaceuticals

Biotech & Life Sciences · Boston, United States · Founded 1992 · IPO 1996 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$39B

Market cap · 2026

Revenue

$8.90B

Latest reported FY

Investors

3 investors on Alexion Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

Oak Investment Partners

Invesco

CHL Medical Partners

Global footprint

Where Alexion Pharmaceuticals has talent and traffic

AI talent share

0.7% of workforce is AI talent
(38 of 5,099 staff)

Core AI70.14%

Other AI310.61%

Non-AI workforce5,06199.25%

Web traffic by country

72K monthly visits
across markets

🇺🇸 United States29.2%

🇮🇳 India16.5%

🇨🇦 Canada10.7%

🇬🇧 United Kingdom7.2%

🇮🇪 Ireland4.6%

Top 5 markets shown

Patent intelligence

$444M patent portfolio · 245 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$444M

1.1% of market cap · 2.4× the top peer Amryt Pharma ($184M)

245 active patent families

Where Alexion Pharmaceuticals innovates DiseaseMolecular biologyAntiendomysial antibodiesAnti antibodyPharmaceutical drug

Below peer median on Market

Quality vs same-sector peers

Alexion Pharmaceuticals on the five Patsnap quality dimensions

Alexion Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Alexion Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Alexion Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Alexion Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo